Roche Personalised Healthcare - from Vision to Reality
On December 1st, Roche presented recent milestones and successes in developing targeted treatment approaches.
Patients with the same diagnosis may react to the same treatment in different ways: While a drug can be highly effective for one patient, the same drug might not show the desired results when given to a second patient with the same diagnosis.
Targeted therapies and diagnostic tests that help to improve medical decision-making not only offer clinical benefits for patients but are also attractive due to their health economic benefits. During the media briefing, clinicians, researchers and other experts provided an insight and first-hand information on Personalised Healthcare and discussed how to bring more clinically differentiated therapies to patients.
|Severin Schwan CEO||Roche Personalised Healthcare: Fitting the treatment to the patient (7.7 MB)|
|Daniel O’Day, COO Roche Diagnostics||The value of diagnostics in Personalised Healthcare|
|Thomas M. Grogan, Prof. of Pathology,|
University of Arizona and Founder Ventana Medical Systems
|Directing cancer therapy with tissue diagnostics: a medical case demonstration (4.5 MB)|
|Dr. Luis Paz-Ares, Chair of Oncology Seville University Hospital in Seville, Spain||Personalised patient care in lung cancer (5 MB)|
|Sean Bohen, MD, PhD, Sr. VP, Research and Early Development, Genentech||Lebrikizumab - a new approach in severe uncontrolled asthma|
|Luca Santarelli, MD, Sr. VP, Head of Neuroscience||Personalizing treatment for brain disorders (4.9 MB)|
|Prof. Thomas Szucs, Director, European Center of Pharmaceutical Medicine & Chairman, Helsana Group||Economic aspects of Personalised Healthcare (5.2 MB)|